Combinations of old antimicrobials such as Helperby’s colistin and azidothymidine are a possible alternative to developing new chemical entities, because they cost one tenth of the price.
A Global Antibiotic Research and Development Partnership (GARDP) Blog on this topic, first published on revive.garpd.org on 15 October 2019 is available below.
Click here to read the full article